Delphia (Usa) Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Delphia (Usa) Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $5,661 - $9,310	-225 Reduced 2.27%	9,698 $345,000
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $64,125 - $104,285	2,708 Added 37.53%	9,923 $252,000
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $202,020 - $292,640	7,215 New	7,215 $292,000
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $172,826 - $314,743	6,219 New	6,219 $219,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.